Published in Crit Care on January 07, 2012
Abandon the mouse research ship? Not just yet! Shock (2014) 2.60
Prognostic Value of Lactate and Central Venous Oxygen Saturation after Early Resuscitation in Sepsis Patients. PLoS One (2016) 1.42
Early administration of corticosteroids and mortality. Crit Care (2012) 0.75
The impact of hydrocortisone treatment on neutrophil gelatinase-associated lipocalin release in porcine endotoxemic shock. Intensive Care Med Exp (2017) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
The impact of confounder selection criteria on effect estimation. Am J Epidemiol (1989) 13.34
Corticosteroid insufficiency in acutely ill patients. N Engl J Med (2003) 6.00
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med (1998) 5.22
SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med (2005) 4.66
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med (1987) 3.89
Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med (1995) 3.74
Factors associated with nonadherence to early goal-directed therapy in the ED. Chest (2010) 3.23
Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med (1999) 3.20
Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med (2005) 3.09
The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med (2006) 2.84
Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med (1995) 2.59
Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med (2002) 2.52
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ (2004) 2.39
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37
Cortisol response to corticotropin and survival in septic shock. Lancet (1991) 2.25
Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med (1987) 2.08
Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets (2006) 1.63
Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol (1998) 1.34
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care (2010) 1.09
Once is not enough: clinical trials in sepsis. Intensive Care Med (2008) 1.04
Corticosteroids in septic shock. N Engl J Med (2008) 1.01
Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit. J Crit Care (2010) 0.93
Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol (2001) 0.91
Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated). Crit Care (2005) 0.85
Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med (2012) 6.73
Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest (2006) 3.66
The role of chest CT scanning in TB outbreak investigation. Chest (2009) 3.62
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med (2010) 3.18
Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 2.78
Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: A comparison with conventional cardiopulmonary resuscitation. Crit Care Med (2011) 2.77
Effect of Early Intervention on Long-Term Outcomes of Critically Ill Cancer Patients Admitted to ICUs. Crit Care Med (2015) 2.66
Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. Clin Infect Dis (2012) 2.23
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis (2008) 2.17
Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol (2015) 2.17
Viral pneumonias in adults: radiologic and pathologic findings. Radiographics (2002) 2.02
Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care (2012) 2.02
Clinical characteristics and efficacy of bronchoscopic intervention for tracheobronchial leiomyoma. Respirology (2008) 1.76
Pleuropulmonary paragonimiasis: CT findings in 31 patients. AJR Am J Roentgenol (2005) 1.76
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2015) 1.68
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2013) 1.62
Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. Chest (2007) 1.60
Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol (2006) 1.51
Serum cytokines and critical illness-related corticosteroid insufficiency. Intensive Care Med (2010) 1.51
Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patient. Intern Med (2004) 1.47
Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers. Support Care Cancer (2013) 1.44
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med (2012) 1.41
Repeated derecruitments accentuate lung injury during mechanical ventilation. Crit Care Med (2013) 1.40
Concurrent endobronchial carcinoid tumor and sarcoidosis. Intern Med (2010) 1.40
Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis (2009) 1.35
Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease. Chest (2012) 1.34
Treatment of thoracic actinomycosis: A retrospective analysis of 40 patients. Ann Thorac Med (2010) 1.28
Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol (2005) 1.28
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy. Chest (2005) 1.25
Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci (2007) 1.25
Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology (2010) 1.24
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J (2012) 1.24
Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer. Lung Cancer (2010) 1.21
Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest (2013) 1.19
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care (2011) 1.17
Predicting factors associated with clinical deterioration of sepsis patients with intermediate levels of serum lactate. Shock (2012) 1.13
Comparison of the Xpert MTB/RIF and Cobas TaqMan MTB assays for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol (2013) 1.11
Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics (2002) 1.09
Solitary pulmonary nodules caused by Mycobacterium tuberculosis and Mycobacterium avium complex. Lung (2009) 1.07
Decreased cytokine production in patients with nontuberculous mycobacterial lung disease. Lung (2007) 1.07
Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med (2013) 1.07
Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med (2012) 1.07
Usefulness of open lung biopsy in mechanically ventilated patients with undiagnosed diffuse pulmonary infiltrates: influence of comorbidities and organ dysfunction. Crit Care (2007) 1.06
The role of endoscopic surgery for completely obstructive endobronchial benign tumor. Korean J Intern Med (2006) 1.06
Prolonged Maintenance of VV ECMO for 104 Days with Native Lung Recovery in Acute Respiratory Failure. ASAIO J (2016) 1.06
Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med (2007) 1.05
Bronchoscopic features and bronchoscopic intervention for endobronchial hamartoma. Respirology (2009) 1.04
Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males. Respir Med (2010) 1.04
Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis (2009) 1.03
Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. Radiology (2012) 1.03
Better lactate clearance associated with good neurologic outcome in survivors who treated with therapeutic hypothermia after out-of-hospital cardiac arrest. Crit Care (2013) 1.02
Prognostic factors in pulmonary tuberculosis requiring mechanical ventilation for acute respiratory failure. Respirology (2007) 1.01
Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med (2010) 1.01
Interferon-γ release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital. Scand J Infect Dis (2010) 0.99
Distribution of nontuberculous mycobacteria by multigene sequence-based typing and clinical significance of isolated strains. J Clin Microbiol (2014) 0.98
Natural stent in the management of post-intubation tracheal stenosis. Respirology (2009) 0.97
Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest (2007) 0.97
Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. J Korean Med Sci (2007) 0.97
Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis (2013) 0.97
Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. J Thorac Oncol (2009) 0.97
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thorac Soc (2013) 0.97
Posttuberculosis tracheobronchial stenosis: use of CT to optimize the time of silicone stent removal. Radiology (2012) 0.96
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. Antimicrob Agents Chemother (2013) 0.95
Treatment of isoniazid-resistant pulmonary tuberculosis. BMC Infect Dis (2008) 0.95
Rigid bronchoscopic intervention in patients with respiratory failure caused by malignant central airway obstruction. J Thorac Oncol (2006) 0.94
Results of interventional bronchoscopy in the management of postoperative tracheobronchial stenosis. J Thorac Cardiovasc Surg (2012) 0.94
Successful treatment with crizotinib in mechanically ventilated patients with ALK positive non-small-cell lung cancer. J Thorac Oncol (2013) 0.94
Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Med J (2010) 0.93
Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. Antimicrob Agents Chemother (2012) 0.93
Complete sequencing of a genetic polymorphism in NAT2 in the Korean population. Clin Chem (2002) 0.93